We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Agile Therapeutics: Q4 Earnings Snapshot
PRINCETON, N.J. (AP) — PRINCETON, N.J. (AP) — Agile Therapeutics Inc. (AGRX) on Thursday reported a loss of $4.5 million in its fourth quarter.
On a per-share basis, the Princeton, New Jersey-based company said it had a loss of $1.51. Losses, adjusted for non-recurring costs, came to $1.46 per share.
The developer of prescription contraceptive products for women posted revenue of $3.6 million in the period.
For the year, the company reported that its loss narrowed to $14.5 million, or $6.71 per share. Revenue was reported as $19.6 million.
The company's shares closed at 37 cents. A year ago, they were trading at $11.75.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AGRX at https://www.zacks.com/ap/AGRX
Copyright 2024, Associated Press, The